Pharming PHAR
NASDAQ PHAR
$9.95 -0.04 (-0.40%)
As of: Oct 1, 2026 · 3:59 PM EDT

Pharming (PHAR) Accumulated Expenses (2019 - 2025)

Updated

Pharming (PHAR) posted Accumulated Expenses of $4.76 million for Q4 2025, up 18.5% from $4.02 million a year earlier.

Analysis

Pharming (PHAR) Accumulated Expenses (2019 - 2025) Analysis & Trends

Since Q4 2019, Pharming has reported Accumulated Expenses for 7 quarters.

  • Annual Accumulated Expenses shows a five-year compound annual growth rate of 0.0% (FY2020 to FY2025).
  • In prior years, Pharming's Accumulated Expenses was $4.02 million in FY2024 (-3.3%), $4.15 million in FY2023 (+104.9%), $2.03 million in FY2022 (-11.5%) and $2.29 million in FY2021 (-51.9%).
  • The Q4 2025 figure stands as the highest quarterly Accumulated Expenses since Q4 2020.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 Pharming 700.98 Mn -129.18 Mn 141.47 Mn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 4.76 Mn
Dec 31, 2024 4.02 Mn
Dec 31, 2023 4.15 Mn
Dec 31, 2022 2.03 Mn
Dec 31, 2021 2.29 Mn
Dec 31, 2020 4.97 Mn
Dec 31, 2019 3.56 Mn
API Access

Pharming Accumulated Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=accumulated-expenses&ticker=PHAR&period=max&api_key=YOUR_API_KEY